Management of late toxicities and specific follow-up needs of adolescent and young adult cancer survivors: recommendations from scientific societies in Spain.

IF 2.5 3区医学 Q2 ONCOLOGY

Clinical & Translational Oncology Pub Date : 2025-09-04 DOI:10.1007/s12094-025-04047-0

Alejandro Pérez Fidalgo, Pilar Alonso, Maitane Andión, Adela Cañete, Erica Collado, Carmen Garrido Colino, José Gómez Codina, Xavier Díaz Carrasco, Ramón García Sanz, Sergio Hernández Expósito, Teresa Lopez-Fernandez, Gabriela Medin, Antonio Molinés, Alberto Moreno Vega, Mónica Ramos, Iñigo San Miguel, Joaquín Sánchez García, Fátima Santolaya

引用次数: 0

Abstract

Adolescent and young adult cancer survivors (AYACS) represent a specific cancer patient population with unique chronic health issues difficult to identify in early, reversible phases with standard monitoring protocols. This review, conducted by a group of Spanish experts, provides recommendations for managing AYACS, focusing on key areas, such as cardiac toxicities, neurotoxicity and neurocognitive disorders, metabolic syndrome, secondary primary malignancies, bone toxicities, sexuality and fertility, psychosocial aspects, and other treatment-related toxicities.

查看原文本刊更多论文

晚期毒性的管理和青少年和青年癌症幸存者的具体随访需求：来自西班牙科学协会的建议。

青少年和年轻成人癌症幸存者（AYACS）代表了一个特殊的癌症患者群体，他们有独特的慢性健康问题，难以在标准监测方案的早期可逆阶段识别。本综述由一组西班牙专家进行，为管理AYACS提供了建议，重点关注关键领域，如心脏毒性、神经毒性和神经认知障碍、代谢综合征、继发性原发性恶性肿瘤、骨毒性、性和生育、社会心理方面以及其他与治疗相关的毒性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical & Translational Oncology 医学-肿瘤学

CiteScore

6.20

自引率

2.90%

发文量

240

审稿时长

1 months

期刊介绍： Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.